Trademark: 97363650
Word
TMALIN
Status
Registered
Status Code
700
Status Date
Tuesday, September 5, 2023
Serial Number
97363650
Registration Number
7159102
Registration Date
Tuesday, September 5, 2023
Mark Type
4000
Filing Date
Thursday, April 14, 2022
Published for Opposition
Tuesday, March 7, 2023

Trademark Owner History

Classifications
5 Vaccines; Anti-cancer preparations; Biological preparations for the treatment of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for treatment of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Cytostatics for pharmaceutical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic reagents for medicinal use; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of antibody-drug conjugate that facilitate the delivery of pharmaceutical preparations; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicinal preparations for anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, elixirs for the treatment of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Therapeutic pharmaceutical for the treatment of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Tumor suppressing agents
The wording "TMALIN" has no meaning in a foreign language.

Trademark Events
Sep 5, 2023
Notice Of Registration Confirmation Emailed
Sep 5, 2023
Registered-Principal Register
Aug 4, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Aug 3, 2023
Allowed Principal Register - Sou Accepted
Aug 3, 2023
Statement Of Use Processing Complete
Jul 18, 2023
Use Amendment Filed
Aug 3, 2023
Case Assigned To Intent To Use Paralegal
Jul 18, 2023
Teas Statement Of Use Received
May 2, 2023
Noa E-Mailed - Sou Required From Applicant
Mar 7, 2023
Official Gazette Publication Confirmation E-Mailed
Mar 7, 2023
Published For Opposition
Feb 15, 2023
Notification Of Notice Of Publication E-Mailed
Feb 1, 2023
Approved For Pub - Principal Register
Feb 1, 2023
Assigned To Examiner
Apr 20, 2022
New Application Office Supplied Data Entered
Apr 18, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24